Mark Schuiveling

Utrecht, UT 3584CG, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 20, 2026

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine

Published: January 23, 2026

Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma.

Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma.

Journal: JAMA oncology

Published: October 16, 2025

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine

Published: March 05, 2025

A novel dataset for nuclei and tissue segmentation in melanoma with baseline nuclei segmentation and tissue segmentation benchmarks.

A novel dataset for nuclei and tissue segmentation in melanoma with baseline nuclei segmentation and tissue segmentation benchmarks.

Journal: GigaScience

Published: October 07, 2024

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.

Journal: Immuno-oncology technology

Published: July 24, 2024

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

Journal: Journal of the National Cancer Institute

Published: May 15, 2024

Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.

Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 26, 2024

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma.

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma.

Journal: Cancer immunology, immunotherapy : CII

Published: June 15, 2020

mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy?

mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy?

Journal: Annals of the rheumatic diseases

Published: October 27, 2018

Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?

Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?

Journal: Current drug targets

Published: February 22, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026